ChloraSolv recommended for UK CA certification required for UK market after Brexit
As a result of Brexit, a so-called UK CA certification will be required for medical devices placed on the market in Great Britain. Today, a positive recommendation for UK CA certification has been provided for RLS Global’s wound debridement product ChloraSolv.“RLS Global has now secured a long-term regulatory compliance, and hence, access to the UK market for ChloraSolv”, says Roland Frösing, acting CEO, RLS Global. RLS Global is now awaiting the formal UK CA certificate. THIS IS CHLORASOLVChloraSolv is a debriding gel, based on a unique hypochlorite technology, which is